These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35644071)

  • 41. Management of benzodiazepine-resistant alcohol withdrawal across a healthcare system: Benzodiazepine dose-escalation with or without propofol.
    Wong A; Benedict NJ; Lohr BR; Pizon AF; Kane-Gill SL
    Drug Alcohol Depend; 2015 Sep; 154():296-9. PubMed ID: 26205315
    [TBL] [Abstract][Full Text] [Related]  

  • 42. De novo absence status epilepticus as a benzodiazepine withdrawal syndrome.
    Thomas P; Lebrun C; Chatel M
    Epilepsia; 1993; 34(2):355-8. PubMed ID: 8384109
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Slow subcutaneous infusion of flumazenil for the treatment of long-term, high-dose benzodiazepine users: a review of 214 cases.
    Faccini M; Leone R; Opri S; Casari R; Resentera C; Morbioli L; Conforti A; Lugoboni F
    J Psychopharmacol; 2016 Oct; 30(10):1047-53. PubMed ID: 27166362
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The benzodiazepines: anxiolytic and withdrawal effects.
    Little HJ
    Neuropeptides; 1991 Jul; 19 Suppl():11-4. PubMed ID: 1679209
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Flumazenil-precipitated panic and dysphoria in patients dependent on benzodiazepines: a possible aid to abstinence.
    Harrison-Read PE; Tyrer P; Lawson C; Lack S; Fernandes C; File SE
    J Psychopharmacol; 1996 Jan; 10(2):89-97. PubMed ID: 22302883
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Flumazenil induces localised increases in glucose utilization during diazepam withdrawal in rats.
    Laurie DJ; Pratt JA
    Brain Res; 1993 Dec; 631(2):277-86. PubMed ID: 8131056
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of oral flumazenil on interictal epileptic activity: results of a double-blind, placebo-controlled study.
    Sharief MK; Sander JW; Shorvon SD
    Epilepsy Res; 1993 May; 15(1):53-60. PubMed ID: 8325278
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of intravenous flumazenil on interictal electroencephalographic epileptic activity: results of a placebo-controlled study.
    Hart YM; Meinardi H; Sander JW; Nutt DJ; Shorvon SD
    J Neurol Neurosurg Psychiatry; 1991 Apr; 54(4):305-9. PubMed ID: 1647443
    [TBL] [Abstract][Full Text] [Related]  

  • 49. GABA
    Müller Herde A; Benke D; Ralvenius WT; Mu L; Schibli R; Zeilhofer HU; Krämer SD
    Neuroimage; 2017 Apr; 150():279-291. PubMed ID: 28192273
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of benzodiazepines on acute and chronic ethanol-induced nociception in rats.
    Gatch MB
    Alcohol Clin Exp Res; 1999 Nov; 23(11):1736-43. PubMed ID: 10591589
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiac effects of benzodiazepine receptor agonists and antagonists in the isolated rat heart: a comparative study.
    Zeegers A; van Wilgenburg H; Leeuwin RS
    Life Sci; 1998; 63(16):1439-56. PubMed ID: 9952290
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of the chronic dose of diazepam on the intensity and characteristics of the precipitated abstinence syndrome in the dog.
    Sloan JW; Martin WR; Wala E
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1152-62. PubMed ID: 8510000
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Flumazenil reverses the decrease in the hypnotic activity of pentobarbital by social isolation stress: are endogenous benzodiazepine receptor ligands involved?
    Ojima K; Matsumoto K; Watanabe H
    Brain Res; 1997 Jan; 745(1-2):127-33. PubMed ID: 9037401
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reversal of central benzodiazepine effects by flumazenil after conscious sedation produced by intravenous diazepam. The Flumazenil in Intravenous Conscious Sedation with Diazepam Multicenter Study Group I.
    Clin Ther; 1992; 14(6):895-909. PubMed ID: 1286497
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of flumazenil on cholecystokinin-tetrapeptide-induced panic symptoms in healthy volunteers.
    Bradwejn J; Koszycki D; Couëtoux du Tertre A; Paradis M; Bourin M
    Psychopharmacology (Berl); 1994 Mar; 114(2):257-61. PubMed ID: 7838917
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Carbamazepine treatment in patients discontinuing long-term benzodiazepine therapy. Effects on withdrawal severity and outcome.
    Schweizer E; Rickels K; Case WG; Greenblatt DJ
    Arch Gen Psychiatry; 1991 May; 48(5):448-52. PubMed ID: 2021297
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation.
    Rickels K; Schweizer E; Case WG; Greenblatt DJ
    Arch Gen Psychiatry; 1990 Oct; 47(10):899-907. PubMed ID: 2222129
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Progesterone modulation of diazepam withdrawal syndrome in mice.
    Pesce ME; Acevedo X; Pinardi G; Miranda HF
    Pharmacol Toxicol; 1996 Dec; 79(6):331-3. PubMed ID: 9000261
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Flumazenil for hepatic coma in patients with liver cirrhosis: an Italian multicentre double-blind, placebo-controlled, crossover study.
    Barbaro G; Di Lorenzo G; Soldini M; Marziali M; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Barbarini G
    Eur J Emerg Med; 1998 Jun; 5(2):213-8. PubMed ID: 9846248
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intravenous flumazenil following prolonged exposure to lormetazepam in humans: lack of precipitated withdrawal.
    Gerra G; Giucasto G; Zaimovic A; Fertonani G; Chittolini B; Avanzini P; Caccavari R; Delsignore R
    Int Clin Psychopharmacol; 1996 Jun; 11(2):81-8. PubMed ID: 8803645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.